Serum ceruloplasmin and ferroxidase activity are not decreased in hepatic failure related to alcoholic cirrhosis: Clinical and pathophysiological implications

Alcoholism: Clinical and Experimental Research

Volumn 28, Issue 5, 2004, Pages 775-779

  Lan, Caroline Le ^a   Ropert, Martine ^a   Lainé, Fabrice ^a   Medevielle, Muriel ^a   Jard, Christine ^b   Pouchard, Michel ^b   Treut, André Le ^a   Moirand, Romain ^a   Loréal, Olivier ^a   Brissot, Pierre ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b Centre d'Examens de Sante CPAM   (France)

Author keywords

Alcoholic Cirrhosis; Ceruloplasmin; Ferroxidase Activity; Iron Overload; Liver Failure

Indexed keywords

ALCOHOL; CERULOPLASMIN; CERULOPLASMIN I; IRON; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CERULOPLASMIN BLOOD LEVEL; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ENZYME ACTIVITY; HUMAN; HYPOTHESIS; IMMUNOASSAY; IRON METABOLISM; LIVER FAILURE; LIVER HEMOSIDEROSIS; MALE; NEPHELOMETRY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; VALIDATION PROCESS; WILSON DISEASE;

ADULT; CERULOPLASMIN; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER FAILURE; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 2442671766     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000125341.42253.C2     Document Type: Article

References (34)

1. Baker HW, Burger HG, De Krester DM, Dulmanis A, Hudson B, O'Connor S, Paulsen CA (1976) A study of endocrine manifestations of hepatic cirrhosis. Q J Med 45:145-178.
2. Becker U, Gluud C (1991) Sex, sex hormones, and chronic liver diseases. Dig Dis 9:9-16.
3. Bianchini A, Musci G, Calabrese L (1999) Inhibition of endothelial nitric-oxide synthetase by ceruloplasmin. J Biol Chem 274:20265-20270.
4. Brissot P (2000) Clinical spectrum of hepatic disease in hemochromatosis, in Hemochromatosis: Genetics, Pathophysiology, Diagnosis and Treatment, Barton and Edwards Editions, Cambridge, pp 250-257.
5. Cauza E, Maier-Dobersberger T, Polli C, Kaserer K, Kramer L, Ferenci F (1997) Screening for Wilson's disease in patients with liver disease by serum ceruloplasmin. J Hepatol 27:358-362.
6. Corpechot C, Barbu V, Wendum D, Kinnman N, Rey C, Poupon R, Housset C, Rosmorduc O (2002) Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology 35:1010-1021.
7. Czaja MJ, Weiner FR, Schwarzenberg SJ, Sternlieb I, Scheinberg IH, Van Thiel DH, LaRusso NF, Giambrone MA, Kirschner R, Koschinsky ML, et al. (1987) Molecular studies of ceruloplasmin deficiency in Wilson's disease. J Clin Invest 80:1200-1204.
8. Erel O (1998) Automated measurement of serum ferroxidase activity. Clin Chem 44:2313-2319.
9. Gerli G, Locatelli GF, Mongiat R, Zenoni L, Agostoni A, Moschini G, Zafiropoulos D, Bruno S, Rossi S, Vignati A, et al. (1992) Erythrocyte antioxidant activity, serum ceruloplasmin, and trace element levels in subjects with alcoholic liver disease. Am J Clin Pathol 97:614-618.
10. Gitlin JD (1988) Transcriptional regulation of ceruloplasmin gene expression during inflammation. J Biol Chem 263:6281-6287.
11. Gutteridge JM (1983) Antioxidant properties of ceruloplasmin towards iron- and copper-dependent oxygen radical formation. FEBS Lett 157:37-40.
12. Harris ED (1993) The transport of copper. Prog Clin Biol Res 380:163-179.
13. Lainé F, Ropert M, Le Lan C, Loréal O, Bellissant E, Jard C, Pouchard M, Le Treut A, Brissot P (2002) Serum ceruloplasmin and ferroxidase activity are decreased in HFE C282Y homozygote male iron-overloaded patients. J Hepatol 36:60-65.
14. Lippi G, Fedi S, Grassi M, Rosi E, Liotta AA, Fontanelli A, Cellai AP, Mazzanti R (1992) Acute phase proteins in alcoholics with or without liver injury. Ital J Gastroenterol 24:383-385.
15. Loréal O, Turlin B, Pigeon C, Moisan A, Ropert M, Morice P, Gandon Y, Jouanolle AM, Verin M, Hider RC, Yoshida K, Brissot P (2002) Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights. J Hepatol 36:851-856.
16. Ludwig J, Haschimoto E, Porayko MK, Moyer TP, Baldus WP (1997) Hemosiderosis in cirrhosis: a study of 447 Native Livers. Gastroenterology 112:882-888.
17. Miyajima H, Takahashi Y, Serizawa M, Kaneko E, Gitlin JD (1996) Increased plasma lipid peroxidation in patients with aceruloplasminemia. Free Radic Biol Med 20:757-760.
18. Moshkov KA, Burmistrov SO, Usatenko MS, Grinenko A, Petrov VP (1986) Ceruloplasmin activity and content of the blood of persons with acute and chronic alcoholic intoxication. Farmakol Toksikol 49:92-96.
19. Mukhopadhyay CK, Attieh ZK, Fox PL (1998) Role of ceruloplasmin in cellular iron uptake. Science 279:714-717.
20. Mukhopadhyay CK, Mazumber B, Fox PL (2000) Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J Biol Chem 275:21048-21054.
21. Murray-Lyon IM, Clarke HG, McPherson K, Williams R (1972) Quantitative immunoelectrophoresis of serum proteins in cryptogenetic cirrhosis, alcoholic cirrhosis and active chronic hepatitis. Clin Chim Acta 39:215-220.
22. Osaki S, Johnson DA, Frieden E (1966) The possible significance of the ferrous oxydase activity of ceruloplasmin in normal human serum. J Biol Chem 241:2746-2751.
23. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646-649.
24. Ramadori G, Van Damme J, Rieder H, Meyer zum Buschenfelde KH (1988) Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1B and tumor necrosis factor alpha. Eur J Immnunol 18:1259-1264.
25. Richardson R (1999) Role of ceruloplasmin and ascorbate in cellular iron release. Lab Clin Med 134:454-465.
26. Ritland S, Skrede S, Johansen O (1982) A long-term follow-up study of the hepatic copper and serum ceruloplasmin concentrations in patients with chronic liver disease. Scand J Gastroenterol 17:545-561.
27. Sato M, Gitlin JD (1991) Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin. J Biol Chem 266:5128-5134.
28. Sherlock S, Dooley J (2002) Diseases, of the Liver and Biliary System. 11th ed, Blackwell Publishing, Oxford, p 417.
29. Skrede S, Solberg HE, Ritland S, Blomhoff JP, Schrumpf E, Elgjo KE (1982) Diagnostic and prognostic value of laboratory tests assessed in follow-up study of 200 patients with liver disease. Clin Chem 28:1177-1181.
30. Song S, Chen JK, Yank PJ, et al (1992) A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel. Contraception 45:523-532.
31. Walshe JM, Briggs J(1962) Ceruloplasmin in liver disease. A diagnostic pitfall. Lancet 2:263-265
32. Whitfield JB, Zhu G, Heath AC, Powell And LW, Martin NG (2001) Effects of alcohol consumption on indices of iron stores and of iron stores on alcohol intake markers. Alcohol Clin Exp Res 25:1037-1045.
33. Wu CT, Lee JN, Shen WW, Lee SL (1984) Serum zinc, copper, and ceruloplasmin levels in male alcoholics. Biol Psychiatry 19:1333-1338.
34. Young S-P, Fahmy M, Golding S (1997) Ceruloplasmin, transferrin and apotransferrin facilitate iron release from human liver cells. FEBS Lett 411:93-96.